Skip to Content

Join the 'Colcrys' group to help and get support from people like you.

Colcrys News

Newly-Published Colchicine Safety Data Provide First Evidence-Based Dosing Guidance to Avoid Potentially Serious Interactions With Commonly Prescribed Drugs

Posted 11 Aug 2011 by Drugs.com

- Paper Published in August Issue of Arthritis & Rheumatism Highlights Several Previously Unknown Drug-Drug Interactions - Colchicine Dose Reductions Necessary in Presence of Certain CYP3A4 or P-gp Inhibitors - Studies Supported URL Pharma Clinical Research Program that Led to FDA Approval of Colcrys® PHILADELPHIA, Aug. 11, 2011 /PRNewswire/ – Newly-published results from a series of ...

FDA Orders Halt to Marketing of Unapproved Single-ingredient Oral Colchicine

Posted 1 Oct 2010 by Drugs.com

Drug commonly used to prevent gout, treat gout flares, and treat Familial Mediterranean Fever (FMF) ROCKVILLE, Md., Sept. 30, 2010--The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the ...

Ask a Question

Further Information

Related Condition Support Groups

Gout - Acute, Gout - Prophylaxis, Familial Mediterranean Fever

Colcrys Patient Information at Drugs.com